PHPer Magnus Humpert

Per Magnus Humpert

*This is an algorithmically generated author record based on publicly available information.

Per Magnus Humpert has a total of 79 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Protective Effects of Transient Glucose Exposure in Adult C. elegans

    by Katharina Murillo, Azat Samigullin, Per M. Humpert, Thomas Fleming, Kübra Özer, Andrea Schlotterer, Hans-Peter Hammes, Michael Morcos

    C. elegans are used to study molecular pathways, linking high glucose levels (HG) to diabetic complications. Persistent exposure of C. elegans to a HG environment induces the mitochondrial formation of reactive oxygen species (ROS) and advanced glycation endproducts (AGEs), leading to neuronal damage and decreased lifespan. Studies suggest that transient high glucose exposure (TGE) exerts different effects than persistent exposure. Thus, the effects of TGE on ROS, AGE-formation and life span were studied in C. elegans. Four-day TGE (400 mM) as compared to controls (0mM) showed a persistent increase of ROS (4-days 286 ± 40 RLUs vs. control 187 ± 23 RLUs) without increased formation of AGEs. TGE increased body motility (1-day 0.14 ± 0.02; 4-days 0.15 ± 0.01; 6-days 0.16 ± 0.02 vs. control 0.10 ± 0.02 in mm/s), and bending angle (1-day 17.7 ± 1.55; 3-days 18.7 ± 1.39; 6-days 20.3 ± 0.61 vs. control 15.3 ± 1.63 in degree/s) as signs of neuronal damage. Lifespan was increased by 27% (21 ± 2.4 days) after one-day TGE, 34% (22 ± 1.2 days) after four-days TGE, and 26% (21 ± 1.4 days) after six-days TGE vs. control (16 ± 1.3 days). These experiments suggest that TGE in C. elegans has positive effects on life span and neuronal function, associated with mildly increased ROS-formation. From the perspective of metabolic memory, hormetic effects outweighed the detrimental effects of a HG environment.


  • Versorgungssituation und Mortalität von Patienten in Deutschland innerhalb und außerhalb des DMP Typ-2-Diabetes: eine kritische Analyse

    by Azat Samigullin, Hans-Peter Hammes, Erhard Siegel, Thomas Helms, Bjoern Andrew Remppis, Per Magnus Humpert, Michael Morcos

    Zusammenfassung: Typ-2-Diabetes(T2 D)-Patienten weisen im Vergleich zur Normalbevölkerung eine erhöhte Sterblichkeit auf. Ein Teil der Patienten ist mit dem Ziel einer besseren Versorgung in das nationale „Disease-Management-Programm Diabetes“ (DMP) Typ-2-Diabetes eingeschlossen. In dieser Arbeit werden Mortalitätsdaten von T2D-Patienten aus der Routineversorgung mit Mortalitätsdaten der Allgemeinbevölkerung und von T2D-Patienten aus verschiedenen Studienkollektiven verglichen. Die Sterblichkeit der deutschen T2D-Patienten insgesamt ist etwa 3,1-fach höher als in der Allgemeinbevölkerung. Die Sterblichkeit von deutschen T2D-Patienten innerhalb des DMP ist 2,4-fach höher. Inwieweit sich dieser Mortalitätsunterschied durch einen Selektionsbias oder durch die Teilnahme am DMP selbst erklären lässt, ist mit den verfügbaren Daten nicht eindeutig zu beantworten. Die Tatsache aber, dass im Vergleich dazu das Sterblichkeitsrisiko innerhalb kontrollierter T2D-Interventionsstudien trotz zusätzlicher kardiovaskulärer Komorbidität nochmals niedriger ist, gibt einen wichtigen Hinweis darauf, dass die kardiovaskuläre Pathophysiologie im bisherigen DMP nicht ausreichend berücksichtigt wird und dieser Tatbestand ein wichtiges Verbesserungspotenzial für eine Optimierung des DMP darstellt.

  • Impaired dexamethasone resorption in two patients with pseudo‐Cushing after bariatric surgery: Implications for immunosuppressive treatment

    by Per M. Humpert, Azat Samigullin, Andre Lindner, Julia Weihrauch, Dimitrios Oikonomou, Cornelia Metzner, Knut A. Böttcher, Michael Morcos

    Summary: Two cases of middle‐aged female patients treated by gastric bypass surgery for weight loss presented to our clinic for a follow‐up examination 3‐6 months after the surgical procedure (a mini gastric bypass and a modified single anastomosis sleeve‐ileostomy). In both patients increased ACTH levels and either high serum cortisol or an increased urinary cortisol excretion was apparent and triggered further endocrine testing. Serum cortisol could not be suppressed adequately by 2 and 4 mg dexamethasone in the standardized oral overnight suppression test while midnight salivary cortisol dropped well below the desired cut‐off. This led to the hypothesis of an impaired dexamethasone resorption and could be further substantiated by suppression of serum cortisol below the cut‐off by an intravenous dexamethasone application. The data presented point to an impairment of enteral synthetic corticosteroid resorption in patients after gastric bypass surgery and could be of importance for individuals in need for immunosuppressive treatment. In view of the growing number of bariatric procedures, pharmacokinetics of corticosteroids and other drugs should be tested in clinical trials.


  • Neuroprotection and antioxidative effects of Sijunzi Tang Decoction in the nematode Caenorhabditis elegans

    by Andrea Schlotterer, Henry Johannes Greten, Bjoern Andrew Remppis, Georgi Kukudov, Thomas Efferth, Jorge Machado, Per Humpert, Hans-Peter Hammes, Michael Morcos


  • Open Access

    Associations of Fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy

    by Marcel Roos, Dimitrios Oikonomou, Maximilian von Eynatten, Peter B Luppa, Uwe Heemann, Jens Lutz, Marcus Baumann, Peter P Nawroth, Angelika Bierhaus, Per M Humpert

    Ambigous results exist on fetuin-A as marker for vascular disease in type 2 diabetes. This study aims to define the role of fetuin-A as marker for micro- and macrovascular disease in a high risk population of patients with type 2 diabetes mellitus and early diabetic nephropathy.


  • Open Access

    External Electric Muscle Stimulation Improves Burning Sensations and Sleeping Disturbances in Patients with Type 2 Diabetes and Symptomatic Neuropathy

    by Per M. Humpert, Michael Morcos, Dimitrios Oikonomou, Karin Schaefer, Andreas Hamann, Angelika Bierhaus, Tobias Schilling, Peter P. Nawroth

    Objective. External muscle stimulation (EMS) of the thighs was previously shown to have beneficial effects in a pilot study on painful diabetic neuro


  • The −174G>C IL-6 Gene Promoter Polymorphism and Diabetic Microvascular Complications

    by G. Rudofsky Jr., A. Schlotterer, P. Reismann, J. Engel, I. A. Grafe, J. Tafel, M. Morcos, P. M. Humpert, P. Nawroth, A. Bierhaus, et al.

    This study examined a possible association of the G>C polymorphism at nucleotide −174 in the promoter region of the interleukin-6 (IL-6) gene (rs1800795) with the prevalence of diabetic complications in 235 patients with type 1 and 498 patients with type 2 diabetes. Genotyping was performed using polymerase chain reaction (PCR) and subsequent cleavage by Nla III restriction endonuclease. Analyzing all diabetic patients together demonstrated that 301 patients (41.1%) carried the GG genotype, 114 (15.6%) the CC genotype, and 318 (43.3%) were heterozygous for the GC genotype. However, there was no correlation of any of the genotypes with the prevalence of diabetic nephropathy or diabetic neuropathy, but subjects with the CC genotype had a significantly higher prevalence of diabetic retinopathy compared to patients with the GC and GG genotype (p=0.016). This association was mainly lost when a logistic regression model was adjusted for diabetes duration (p=0.07). Consistently, a weak but not significant association of the polymorphism with diabetic retinopathy was observed when type 1 and type 2 diabetic patients were analyzed separately (patients with type 1 diabetes: p=0.12; patients with type 2 diabetes: p=0.09). Analogically, no association of the polymorphism was found for diabetic nephropathy or diabetic neuropathy in these groups. In conclusion these data suggest no major influence of the −174G>C variant in the promoter region of the IL-6 gene on the development of microvascular complications in patients with diabetes.


  • Open Access

    Insulin Stimulates the Clonogenic Potential of Angiogenic Endothelial Progenitor Cells by IGF-1 Receptor-Dependent Signaling

    by Per M. Humpert, Zdenka Djuric, Ulf Zeuge, Dimitrios Oikonomou, Yuri Seregin, Klaus Laine, Volker Eckstein, Peter P. Nawroth, Angelika Bierhaus

    Endothelial progenitor cells (EPCs) have been shown to be involved in vascular regeneration and angiogenesis in experimental diabetes. Because insulin therapy mobilizes circulating progenitor cells, we studied the effects of insulin on outgrowth of EPCs from peripheral blood mononuclear cells of healthy volunteers and patients with type 2 diabetes. Insulin increased the formation of EPC colony-forming units in a dose-dependent manner, half-maximal at 1.5 nM and peaking at 15 nM. Inhibiting the insulin receptor with neutralizing antibodies or antisense oligonucleotides had no effect on EPC outgrowth.(1) In contrast, targeting the human insulin-like growth factor 1 (IGF-1) receptor with neutralizing antibodies significantly suppressed insulin-induced outgrowth of EPCs from both healthy controls and patients with type 2 diabetes. This IGF-1 receptor-mediated insulin effect on EPC growth was at least in part dependent on MAP kinases(2) and was abrogated when extracellular signal-regulated kinase 1/2 (Erk1/2) and protein kinase 38 (p38) activity was inhibited. To study the functional relevance of the observed insulin effects, we studied EPC-induced tube formation of bovine endothelial cells in vitro. Insulin-stimulated EPCs incorporated into the endothelial tubes and markedly enhanced tube formation. In conclusion, this is the first study showing an insulin-mediated activation of the IGF-1 receptor leading to an increased clonogenic and angiogenic potential of EPCs in vitro.